Gilead Sciences (GILD) on Watch Following CMS Blog Post

November 14, 2016 2:07 PM EST

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Gilead Sciences (NASDAQ: GILD) was in focus after it was mentioned in a CMS blog post discussing the increase in costs of prescription drugs.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Trader Talk

Add Your Comment